BeiGene Market Cap

BeiGene has a market cap or net worth of 214.79 billion as of April 2, 2025. Its market cap has increased by 69.58% in one year.

Market Cap

214.79B

Enterprise Value

203.54B

Revenue

27.81B

Ranking

n/a

PE Ratio

n/a

Stock Price

250.80

Market Cap Chart

Since February 3, 2016, BeiGene's market cap has increased from 5.65B to 214.79B, an increase of 3,702.52%. That is a compound annual growth rate of 48.72%.

Market Cap History

Date	Market Cap	% Change
Apr 2, 2025	214.79B	49.62%
Dec 31, 2024	143.55B	7.76%
Dec 29, 2023	133.21B	-15.45%
Dec 30, 2022	157.55B	-10.93%
Dec 31, 2021	176.88B	15.32%
Dec 31, 2020	153.38B	117.37%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Jiangsu Hengrui Medicine	312.84B
Shenzhen Mindray Bio-Medical Electronics	283.00B
WuXi AppTec	193.37B
Aier Eye Hospital Group	123.47B
Zhangzhou Pientzehuang Pharmaceutical.,	122.02B
Yunnan Baiyao Group Co.,Ltd	101.35B
Shanghai United Imaging Healthcare	99.90B
Sichuan Biokin Pharmaceutical	93.16B

Market Cap Rankings